Elmex Gel Efficacy in Preventing White Spot Lesions

NCT ID: NCT00268138

Last Updated: 2009-02-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

314 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-04-30

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the objective of this phase IV study: to establish the efficacy of elmex gel with a fluoride concentration of 1.25% compared with placebo by determining prevention of white spot lesions in patients wearing fixed orthodontic appliances.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

314 healthy subjects undergoing orthodontic treatment will be examined. follow up will take place from bonding the appliance till debonding, at least 12 months and no more than 30 months.

tooth brushing with product (test product or control) once per week during the entire study.

4 times a year additional tray application of test product or control. subjects wiil clean their teeth with the toothpaste they usually use during the entire study.

toothbrush and a sandglass will be provided every 6 weeks

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Caries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

elmex gel

elmex gel once a week

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

fluoride

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* treatment plan: minimum of 10 teeth to be bonded labially at least 10 years old
* written declaration of informed consent

Exclusion Criteria

* known allergy to components of test products
* handicapped patients who have difficulties brushing their teeth
* pathological desquamation changes
* known pregnancy, breast feeding
* eating disorders
* disease that effect dental hard tissue
* participation in another clinical trial either currently or within the lase 30 days
Minimum Eligible Age

10 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gaba International AG

INDUSTRY

Sponsor Role collaborator

Hadassah Medical Organization

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hadassah

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Meir Redlich, DMD PhD

Role: PRINCIPAL_INVESTIGATOR

Hadassah Medical Center, Dept of Orthodontics

Paul George Jost-Brinkmann, Prof

Role: PRINCIPAL_INVESTIGATOR

Charite - Berlin, Dept of Orthodontics, Center of Dentistry

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Charite University

Berlin, , Germany

Site Status RECRUITING

Hadassah Medical Organization, Jerusalem, Israel

Jerusalem, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Andrea Engl, Dr.

Role: CONTACT

++41614156056

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Paul-Georg Jost-Brinkmann, Prof

Role: primary

++4930450562532

Arik tzukert, DMD

Role: primary

00 972 2 6776095

Hadas Lemberg, Phd

Role: backup

00 972 2 6777572

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

123456-HMO-CTIL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.